Application 022504
- Type
- NDA
- Sponsor
- ELI LILLY AND CO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AXIRON | TESTOSTERONE | SOLUTION, METERED;TRANSDERMAL | 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022504-001 | AXIRON | TESTOSTERONE | 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION, METERED / TRANSDERMAL | RLD | 2010-11-23 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022504-001 | 8993520 | 2026-06-02 | U-1390 | 2015-04-09 | |
| N022504-001 | 9180194 | 2026-06-02 | U-1390 | 2015-12-03 | |
| N022504-001 | 8419307 | 2027-02-26 | U-1386 | 2013-04-30 | |
| N022504-001 | 8807861 | 2027-02-26 | U-1563 | Drug product | 2014-09-10 |
| N022504-001 | 9289586 | 2027-02-26 | U-1390 | 2016-04-19 | |
| N022504-001 | 8435944 | 2027-09-27 | U-1390 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N022504-001 | AXIRON | 30MG/1.5ML ACTUATION **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION, METERED / TRANSDERMAL | RLD | 2010-11-23 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N022504-001 | 8993520 | 2026-06-02 | U-1390 | 2015-04-09 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N022504-001 | 9180194 | 2026-06-02 | U-1390 | 2015-12-03 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N022504-001 | 8419307 | 2027-02-26 | U-1386 | 2013-04-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N022504-001 | 8807861 | 2027-02-26 | U-1563 | Drug product | 2014-09-10 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | N022504-001 | 9289586 | 2027-02-26 | U-1390 | 2016-04-19 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | N022504-001 | 8435944 | 2027-09-27 | U-1390 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Testosterone | TESTOSTERONE | Encube Ethicals, Inc. | ca5d4865-356b-45e7-b603-fe299e450abc | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| TESTOSTERONE | TESTOSTERONE | Encube Ethicals, Inc. | 44a04f66-fd2a-45c7-934e-8f14c023ce14 | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Northstar Rx LLC | 65981b8a-d5cc-1964-7eac-a07f032c2571 | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Xiromed, LLC | 28e8d504-5073-1d78-f351-bcb7c5188ee6 | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Lupin Pharmaceuticals, Inc. | 29c8846f-121c-4958-9e03-3bd271c21558 | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Lupin Pharmaceuticals, Inc. | 61387416-510d-40c5-9e2d-24bfb7f56d08 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Bryant Ranch Prepack | c6c0a39e-0e75-4356-a052-c26c30c76b26 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Actavis Pharma, Inc. | 5834d34f-839d-412c-b74c-da1dad2cfa88 | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Actavis Pharma, Inc. | e18b4495-c5a3-4a7f-9636-179320784381 | 2025-09-29 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Bryant Ranch Prepack | 6c7d2dec-6492-4d53-b110-61ffeae9ee61 | 2025-09-03 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| testosterone | TESTOSTERONE | Northstar Rx LLC | 2d55b825-8eab-4091-bdf2-9c52d111b8eb | 2025-08-31 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| testosterone | TESTOSTERONE | Padagis Israel Pharmaceuticals Ltd | 54fcdcb9-fb0e-4164-9e51-f2a5feae3217 | 2025-08-31 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Strides Pharma Science Limited | ee54c393-bcfe-4a52-b7b3-1da8750f35d9 | 2025-08-22 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Testosterone | TESTOSTERONE | Actavis Pharma, Inc. | 4f3c2c0a-7dab-4b50-9cae-869c3c2a8498 | 2025-08-01 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| testosterone | TESTOSTERONE | Bryant Ranch Prepack | 9e10a37a-9c40-456b-a362-2fa8eae31e84 | 2025-07-29 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Natesto nasal gel | TESTOSTERONE | Acerus Pharmaceuticals Corporation | dea6bed1-eaca-11e3-ac10-0800200c9a66 | 2025-07-22 | Warnings, Adverse reactions | TESTOSTERONE |
| Testopel | TESTOSTERONE | Endo USA, Inc. | 03b9c0b1-5884-11e4-8ed6-0800200c9a66 | 2025-07-17 | Warnings, Adverse reactions | TESTOSTERONE |
| Testim | TESTOSTERONE | Endo USA, Inc. | 9f2aae1f-898d-4955-be31-678e0cf85395 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| Vogelxo | TESTOSTERONE | Upsher-Smith Laboratories, LLC | 2dd150f6-cdfd-4d51-8888-12b288f26262 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
| TESTOSTERONE | TESTOSTERONE | Alembic Pharmaceuticals Inc. | e39289aa-681c-47ec-9461-52e7f17e5d71 | 2025-07-14 | Boxed warning, Warnings, Adverse reactions | TESTOSTERONE |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 48988 | SUPPL | 2017-07-14 |
| 48982 | SUPPL | 2017-07-14 |
| 48981 | SUPPL | 2017-07-14 |
| 47127 | SUPPL | 2017-02-07 |
| 47100 | SUPPL | 2017-02-06 |
| 46988 | SUPPL | 2017-01-27 |
| 45744 | SUPPL | 2016-11-01 |
| 45678 | SUPPL | 2016-10-27 |
| 29792 | SUPPL | 2015-05-13 |
| 17653 | SUPPL | 2015-05-13 |
| 42542 | SUPPL | 2014-07-07 |
| 38770 | SUPPL | 2014-06-23 |
| 7465 | SUPPL | 2014-06-23 |
| 29791 | SUPPL | 2011-12-28 |
| 17652 | SUPPL | 2011-12-23 |
| 44763 | ORIG | 2011-09-16 |
| 22038 | ORIG | 2011-09-16 |
| 44506 | ORIG | 2011-04-04 |
| 29790 | SUPPL | 2011-04-04 |
| 17651 | SUPPL | 2011-04-01 |
| 29789 | ORIG | 2010-11-29 |
| 38769 | ORIG | 2010-11-23 |